脂肪来源干细胞在手部与颅面外科的基础科学进展与应用更新
本文综述脂肪来源干细胞(ADSC)在手部与颅面外科中的基础科学进展与临床应用,涵盖其分化潜能、自我更新与易分离特性,重点讨论细胞辅助脂肪移植(CAL)的循证证据、ADSC采集与分离的最佳实践、操作标准化需求,以及美国FDA监管挑战与未来应用前景。
要点
- ADSC因多向分化、自我更新和易分离特性,为传统脂肪移植提供细胞辅助脂肪移植(CAL)新策略。
- CAL在临床实践中的完整意义尚未充分明确,亟需评估支持ADSC干预的科学证据。
- ADSC采集与分离的最佳实践及操作标准化是阐明其科学基础的关键。
核心结论
- ADSC疗法为治疗选择有限的患者提供新替代方案,但其临床意义仍需进一步评估。
- 操作标准化将有助于阐明ADSC广泛使用的科学基础。
研究设计与样本
- 本文为综述,全面评估支持ADSC衍生疗法的最佳循证实践。
- 聚焦组织工程与再生医学在整形与重建外科中的已知机制。
主要发现
- ADSC具有广泛分化潜能、自我更新能力和易分离特性。
- 过去十年,整形外科医生尝试利用ADSC改善传统脂肪移植的存活率,即细胞辅助脂肪移植(CAL)。
- CAL在临床实践中的完整意义尚未充分理解。
临床怎么用
- 本文概述ADSC采集与分离的最佳实践。
- 强调操作标准化以阐明ADSC广泛使用的科学基础。
- 讨论美国FDA监管对细胞疗法的影响及ADSC在整形外科未来的角色。
局限性
- CAL在临床实践中的完整意义尚未充分理解。
- 需要评估支持ADSC干预的科学证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adipose-derived stem cell therapy offers plastic surgeons a novel treatment alternative for conditions with few therapeutic options. Adipose-derived stem cells are a promising treatment because of their broad differentiation potential, capacity for self-renewal, and ease of isolation. Over the past decade, plastic surgeons have attempted to harness adipose-derived stem cells' unique cellular characteristics to improve the survival of traditional fat grafting procedures, a process known as cell-assisted lipotransfer. However, the full implications of cell-assisted lipotransfer in clinical practice remain incompletely understood, stressing the urgent need to assess the scientific evidence supporting adipose-derived stem cell-based interventions. Furthermore, with the strict regulatory climate surrounding tissue explantation therapies, reviewing the safety and efficacy of these treatments will clarify their regulatory viability moving forward. In this report, the authors provide a comprehensive, up-to-date appraisal of best evidence-based practices supporting adipose-derived stem cell-derived therapies, highlighting the known mechanisms behind current clinical applications in tissue engineering and regenerative medicine specific to plastic and reconstructive surgery. The authors outline best practices for the harvest and isolation of adipose-derived stem cells and discuss why procedure standardization will elucidate the scientific bases for their broad use. Finally, the authors discuss challenges posed by U.S. Food and Drug Administration oversight of these cell-based therapies and examine the role of adipose-derived stem cell-based applications in the future of plastic surgery.
引用
- Lynch EB, Anderson WM, DeCoster RC, et al. Update on the Basic Science Concepts and Applications of Adipose-Derived Stem Cells in Hand and Craniofacial Surgery. Plast Reconstr Surg. 2021. PMID: 34432707. doi:10.1097/PRS.0000000000008279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。